The feasibility of dexamethasone omission in weekly paclitaxel treatment for breast cancer patients

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

N.K. Aaronson, Sam H. Ahmedzai, Bengt Bergman et al. · JNCI Journal of the National Cancer Institute · 1993 · 16K citations

Pharmacy, Oncology, Cancer Symptom Management +15

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

Joseph A. Sparano, Molin Wang, Silvana Martino et al. · New England Journal of Medicine · 2008 · 1K citations · Full text

Medicine, Oncology, Pharmacology +13

Quality of life of Danish women: Population-based norms for the EORTC QLQ-C30

M. Klee · Quality of Life Research · 1997 · 136 citations

Pharmacy, Population Health Sciences, Women's Health +9

Hypersensitivity Reactions and the Utility of Oral and Intravenous Desensitization in Patients with Gynecologic Malignancies

Jubilee B. Robinson, Diljeet K. Singh, Diane C. Bodurka et al. · Gynecologic Oncology · 2001 · 112 citations

Medicine, Gynecology, Oncology +14

Premedication Strategy for Weekly Paclitaxel

Justin Quock, Gilland Dea, Michael Tanaka et al. · Cancer Investigation · 2002 · 44 citations

Medicine, Pharmacology, Pharmacotherapy +13